MentionFox
Home › Executive changes › Applied Therapeutics, Inc.
Leadership changes · APLT · SEC Form 8-K, Item 5.02

Leadership changes at Applied Therapeutics, Inc. (2026)

Before you join, sell to or invest in Applied Therapeutics, Inc.

MentionFox check on Applied Therapeutics, Inc.: only 1 source on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/applied-therapeutics

Check Applied Therapeutics, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Applied Therapeutics, Inc.?

Who joined and who left Applied Therapeutics, Inc. (APLT)? 1 filing reported on 2026-02-03, each cited to the company's own filing.

As of November 14, 2026, Applied Therapeutics, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on February 3, 2026 (Form 8-K, February 3, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

Propel Bio Management, LLC also filed stake reports on 1 other company ↓

Sell to companies like Applied Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
Latest filing2026-02-03

Applied Therapeutics, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-02-03. Every row below is cited to the filing it comes from, and this page adds each new change as Applied Therapeutics, Inc. files it.

Also on the record for Applied Therapeutics, Inc.

DateRecordFigureOur pageSource
February 17, 2026Stake report, Schedule 13G/A, by Vestal Point Capital, LP—5%+ stakesSource
December 31, 2025Stake report, Schedule 13G/A, by Propel Bio Management, LLC4.2% of the class5%+ stakesSource
December 15, 2025Stake report, Schedule 13G/A, by Alexandria Real Estate Equities, Inc.4.3% of the class5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by T. Rowe Price Investment Management, Inc.14.9% of the class5%+ stakesSource
August 14, 2025Stake report, Schedule 13G/A, by T. Rowe Price Investment Management, Inc.13.2% of the class5%+ stakesSource
July 29, 2025Stake report, Schedule 13G/A, by The Vanguard Group3.34% of the class5%+ stakesSource
July 16, 2025Stake report, Schedule 13G/A, by BlackRock, Inc.3.7% of the class5%+ stakesSource

Selling to them or working with them? See who runs Applied Therapeutics, Inc. now and the warning signs.

Free to see. No signup.

Keep reading

More on Applied Therapeutics, Inc. and the records around it.

Applied Therapeutics, Inc. elsewhere on the record

Companies that share a holder

Want the whole picture on Applied Therapeutics, Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Applied Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Applied Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    8 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-02-03Reportednot named in the filing8-K, 2026-02-03
Selling to Applied Therapeutics, Inc.?

New leaders reset buying decisions — get the Full Report on Applied Therapeutics, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Applied Therapeutics, Inc.

Hiring for a seat like this?

Find people with the same kind of experience as the senior executive at Applied Therapeutics, Inc., with the record behind each one.

Find candidates like senior executive at Applied Therapeutics, Inc.

Every change, in the filing's words

Filed 2026-02-03 · 8-K

Reported

Pursuant to the Merger Agreement, and effective at the Effective Time, each of Les Funtleyder, Teena Lerner, Jay S. Skylar and Stacy J. Kanter resigned as directors of the Company and members of any committee of the Company's board of directors.

Also stated in this filing

  • In connection with the Merger and as contemplated by the Merger Agreement, upon the consummation of the Merger, the sole director of Purchaser, James Harrison, became the sole director of the Company at the Effective Time.
  • As a result of the Merger, as of the Effective Time, each of Les Funtleyder, Evan Bailey, Dale Hooks, Constantine Chinoporos, and Todd Baumgartner ceased serving as an officer of the Company.
  • Further, pursuant to the Merger Agreement, effective as of the Effective Time, James Harrison, as President of Purchaser immediately prior to the Effective Time, became the President of the Company, and Andrea Reiner, as Secretary of Purchaser immediately prior to the Effective Time, became the Secretary of the Company.

Tools for this story

Each opens in a new tab, filled in for Applied Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/applied-therapeutics
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
What changed at the top of Applied Therapeutics, Inc.?. MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/applied-therapeutics